PDF herunterladen
Horm Metab Res 2010; 42(6): 416-423
DOI: 10.1055/s-0029-1243602
Review

© Georg Thieme Verlag KG Stuttgart · New York

Aberrant Hormone Receptors in Primary Aldosteronism

T. L. Mazzuco1 , S. Grunenwald1 , A. Lampron1 , I. Bourdeau1 , A. Lacroix1
  • 1Division of Endocrinology, Department of Medicine, Centre de recherche du Centre hospitalier de l’Université de Montréal (CRCHUM), Université de Montréal, Montréal, Canada
Weitere Informationen

Publikationsverlauf

received 13.10.2009

accepted 23.11.2009

Publikationsdatum:
07. Januar 2010 (online)

Auch verfügbar auf
    Lizenzen und Reprints

Abstract

The mechanisms involved in the renin-independent regulation of aldosterone secretion in primary aldosteronism are poorly understood. In ACTH-independent Cushing's syndrome, cortisol secretion can be regulated by the aberrant expression of G-protein coupled receptors (GPCRs) in unilateral tumors and bilateral macronodular adrenal hyperplasia. By analogy, some recent studies identified overexpression or function of several GPCR as a potential cause for excess aldosterone production in some aldosteronomas and in bilateral idiopathic hyperaldosteronism. Initial studies have used in vitro techniques, while the clinical aldosterone responses were not assessed. More recently, several receptors have been shown to be expressed in aldosterone-producing adrenal tumors in vitro and to regulate aberrantly renin-independent aldosterone secretion in vivo. The prevalence of aberrant hormone receptors in primary aldosteronism could be elevated, but larger systematic studies are required to establish its true frequency. The identification of aberrant adrenal GPCRs by in vivo functional studies offers the potential for novel pharmacological therapies that either suppress the endogenous ligands or block the receptor with specific antagonists.

Key words

primary aldosteronism - adrenal glands - G-protein coupled receptors - aldosterone

References

  • 1 Lacroix A, Baldacchino V, Bourdeau I, Hamet P, Tremblay J. Cushing's syndrome variants secondary to aberrant hormone receptors.  Trends Endocrinol Metab. 2004;  15 375-382
    Google Scholar
  • 2 Lacroix A, Bourdeau I, Lampron A, Mazzuco TL, Tremblay J, Hamet P. Aberrant G-protein coupled receptor expression in relation to adrenocortical overfunction.  Clin Endocrinol (Oxf). 2009;  E-pub Aug 29  DOI: 10.1111/j.1365-2265.2009.03689.x 
    Google Scholar
  • 3 Arnaldi G, Mancini V, Costantini C, Giovagnetti M, Petrelli M, Masini A, Bertagna X, Mantero F. ACTH receptor mRNA in human adrenocortical tumors: overexpression in aldosteronomas.  Endocr Res. 1998;  24 845-849
    Google Scholar
  • 4 Lampron A, Bourdeau I, Oble S, Godbout A, Schurch W, Arjane P, Hamet P, Lacroix A. Regulation of aldosterone secretion by several aberrant receptors including for glucose-dependent insulinotropic peptide in a patient with an aldosteronoma.  J Clin Endocrinol Metab. 2009;  94 750-756
    Google Scholar
  • 5 Zwermann O, Suttmann Y, Bidlingmaier M, Beuschlein F, Reincke M. Screening for Membrane Hormone Receptor Expression in Primary Aldosteronism.  Eur J Endocrinol. 2009;  160 443-451
    Google Scholar
  • 6 Schubert B, Fassnacht M, Beuschlein F, Zenkert S, Allolio B, Reincke M. Angiotensin II type 1 receptor and ACTH receptor expression in human adrenocortical neoplasms.  Clin Endocrinol (Oxf). 2001;  54 627-632
    Google Scholar
  • 7 Lefebvre H, Cartier D, Duparc C, Lihrmann I, Contesse V, Delarue C, Godin M, Fischmeister R, Vaudry H, Kuhn JM. Characterization of serotonin(4) receptors in adrenocortical aldosterone-producing adenomas: in vivo and in vitro studies.  J Clin Endocrinol Metab. 2002;  87 1211-1216
    Google Scholar
  • 8 Lacroix A, Tremblay J, Rousseau G, Bouvier M, Hamet P. Propranolol therapy for ectopic beta-adrenergic receptors in adrenal Cushing's syndrome.  N Engl J Med. 1997;  337 1429-1434
    Google Scholar
  • 9 Willenberg HS, Schinner S, Ansurudeen I. New mechanisms to control aldosterone synthesis.  Horm Metab Res. 2008;  40 435-441
    Google Scholar
  • 10 Williams GH. Aldosterone biosynthesis, regulation, and classical mechanism of action.  Heart Fail Rev. 2005;  10 7-13
    Google Scholar
  • 11 Capponi AM. The control by angiotensin II of cholesterol supply for aldosterone biosynthesis.  Mol Cell Endocrinol. 2004;  217 113-118
    Google Scholar
  • 12 Gupta P, Franco-Saenz R, Mulrow PJ. Locally generated angiotensin II in the adrenal gland regulates basal, corticotropin-, and potassium-stimulated aldosterone secretion.  Hypertension. 1995;  25 443-448
    Google Scholar
  • 13 Mazzocchi G, Malendowicz LK, Macchi C, Gottardo G, Nussdorfer GG. Further investigations on the effects of neuropeptide Y on the secretion and growth of rat adrenal zona glomerulosa.  Neuropeptides. 1996;  30 19-27
    Google Scholar
  • 14 Bornstein SR, Chrousos GP. Clinical review 104: Adrenocorticotropin (ACTH)- and non-ACTH-mediated regulation of the adrenal cortex: neural and immune inputs.  J Clin Endocrinol Metab. 1999;  84 1729-1736
    Google Scholar
  • 15 Gallo-Payet N, Grazzini E, Cote M, Chouinard L, Chorvatova A, Bilodeau L, Payet MD, Guillon G. Role of Ca2+ in the action of adrenocorticotropin in cultured human adrenal glomerulosa cells.  J Clin Invest. 1996;  98 460-466
    Google Scholar
  • 16 Feige JJ, Keramidas M, Chambaz EM. Hormonally regulated components of the adrenocortical cell environment and the control of adrenal cortex homeostasis.  Horm Metab Res. 1998;  30 421-425
    Google Scholar
  • 17 Otis M, Campbell S, Payet MD, Gallo-Payet N. Expression of extracellular matrix proteins and integrins in rat adrenal gland: importance for ACTH-associated functions.  J Endocrinol. 2007;  193 331-347
    Google Scholar
  • 18 Missale C, Memo M, Liberini P, Spano P. Dopamine selectively inhibits angiotensin II-induced aldosterone secretion by interacting with D-2 receptors.  J Pharmacol Exp Ther. 1988;  246 1137-1143
    Google Scholar
  • 19 Kasprzak A, Rebuffat P, Andreis PG, Mazzocchi G, Nussdorfer GG. Effects of prolonged cysteamine administration on the rat adrenal cortex: evidence that endogenous somatostatin is involved in the control of the growth and steroidogenic capacity of zona glomerulosa.  J Steroid Biochem Mol Biol. 1991;  38 469-473
    Google Scholar
  • 20 Cherradi N, Brandenburger Y, Rossier MF, Vallotton MB, Stocco DM, Capponi AM. Atrial natriuretic peptide inhibits calcium-induced steroidogenic acute regulatory protein gene transcription in adrenal glomerulosa cells.  Mol Endocrinol. 1998;  12 962-972
    Google Scholar
  • 21 Gallo-Payet N, Guillon G. Regulation of adrenocortical function by vasopressin.  Horm Metab Res. 1998;  30 360-367
    Google Scholar
  • 22 Lefebvre H, Gonzalez KN, Contesse V, Delarue C, Vaudry H, Kuhnl JM. Effect of prolonged administration of the serotonin4 (5-HT4) receptor agonist cisapride on aldosterone secretion in healthy volunteers.  Endocr Res. 1998;  24 749-752
    Google Scholar
  • 23 Hinson JP, Kapas S, Orford CD, Vinson GP. Vasoactive intestinal peptide stimulation of aldosterone secretion by the rat adrenal cortex may be mediated by the local release of catecholamines.  J Endocrinol. 1992;  133 253-258
    Google Scholar
  • 24 Gross MD, Grekin RJ, Gniadek TC, Villareal JZ. Suppression of aldosterone by cyproheptadine in idiopathic aldosteronism.  N Engl J Med. 1981;  305 181-185
    Google Scholar
  • 25 Ganguly A, Pratt JH, Weinberger MH, Grim CE, Fineberg NS. Differing effects of metoclopramide and adrenocorticotropin on plasma aldosterone levels in glucocorticoid-suppressible hyperaldosteronism and other forms of hyperaldosteronism.  J Clin Endocrinol Metab. 1983;  57 388-392
    Google Scholar
  • 26 Mantero F, Rocco S, Opocher G, Armanini D, Boscaro M, D’Agostino D. Effect of ketanserin in primary aldosteronism.  J Cardiovasc Pharmacol. 1985;  7 ((Suppl 7)) S172-S175
    Google Scholar
  • 27 Lefebvre H, Contesse V, Delarue C, Soubrane C, Legrand A, Kuhn JM, Wolf LM, Vaudry H. Effect of the serotonin-4 receptor agonist zacopride on aldosterone secretion from the human adrenal cortex: in vivo and in vitro studies.  J Clin Endocrinol Metab. 1993;  77 1662-1666
    Google Scholar
  • 28 Lefebvre H, Dhib M, Godin M, Contesse V, Delarue C, Rieu M, Wolf LM, Vaudry H, Kuhn JM. Effect of the serotonin 5-HT4 receptor agonist cisapride on aldosterone secretion in corticotropic insufficiency and primary hyperaldosteronism.  Neuroendocrinology. 1997;  66 229-233
    Google Scholar
  • 29 Nomura K, Toraya S, Horiba N, Ujihara M, Aiba M, Demura H. Plasma aldosterone response to upright posture and angiotensin II infusion in aldosterone-producing adenoma.  J Clin Endocrinol Metab. 1992;  75 323-327
    Google Scholar
  • 30 Perraudin V, Delarue C, Lefebvre H, Do Rego JL, Vaudry H, Kuhn JM. Evidence for a role of vasopressin in the control of aldosterone secretion in primary aldosteronism: in vitro and in vivo studies.  J Clin Endocrinol Metab. 2006;  91 1566-1572
    Google Scholar
  • 31 Schorr I, Ney RL. Abnormal hormone responses of an adrenocortical cancer adenyl cyclase.  J Clin Invest. 1971;  50 1295-1300
    Google Scholar
  • 32 Schorr I, Rathnam P, Saxena BB, Ney RL. Multiple specific hormone receptors in the adenylate cyclase of an adrenocortical carcinoma.  J Biol Chem. 1971;  246 5806-5811
    Google Scholar
  • 33 Hinshaw HT, Ney RL. Abnormal hormonal control in the neoplastic adrenal cortex. In: Mckerns K W (ed). Hormones and cancer. New York: Academic press 1974: 309-327
    Google Scholar
  • 34 Lacroix A, Ndiaye N, Tremblay J, Hamet P. Ectopic and abnormal hormone receptors in adrenal Cushing's syndrome.  Endocr Rev. 2001;  22 75-110
    Google Scholar
  • 35 Mune T, Murase H, Yamakita N, Fukuda T, Murayama M, Miura A, Suwa T, Hanafusa J, Daido H, Morita H, Yasuda K. Eutopic overexpression of vasopressin v1a receptor in adrenocorticotropin-independent macronodular adrenal hyperplasia.  J Clin Endocrinol Metab. 2002;  87 5706-5713
    Google Scholar
  • 36 Cartier D, Jegou S, Parmentier F, Lihrmann I, Louiset E, Kuhn JM, Bastard C, Plouin PF, Godin M, Vaudry H, Lefebvre H. Expression profile of serotonin4 (5-HT4) receptors in adrenocortical aldosterone-producing adenomas.  Eur J Endocrinol. 2005;  153 939-947
    Google Scholar
  • 37 Christopoulos S, Cartier D, Yared Z, Bourdeau I, Lefebvre H, Lacroix A. Serotonin (5-HT4) Receptor Isoform Characterization in a 5-HT4 agonist-responsive ACTH-Independent Macronodular Adrenal Hyperplasia (AIMAH) causing Primary Hyperaldosteronism and Cyclical Cushing's Syndrome (CS).  The Endocrine Society 87th Meeting, San Diego. 2005;  Abstract P1-634 
    Google Scholar
  • 38 Rossi GP, Sticchi D, Giuliani L, Bernante P, Zavattiero S, Pessina AC, Nussdorfer GG. Adiponectin receptor expression in the human adrenal cortex and aldosterone-producing adenomas.  Int J Mol Med. 2006;  17 975-980
    Google Scholar
  • 39 Saner-Amigh K, Mayhew BA, Mantero F, Schiavi F, White PC, Rao CV, Rainey WE. Elevated expression of luteinizing hormone receptor in aldosterone-producing adenomas.  J Clin Endocrinol Metab. 2006;  91 1136-1142
    Google Scholar
  • 40 Ye P, Mariniello B, Mantero F, Shibata H, Rainey WE. G-protein-coupled receptors in aldosterone-producing adenomas: a potential cause of hyperaldosteronism.  J Endocrinol. 2007;  195 39-48
    Google Scholar
  • 41 Mariniello B, Sartorato P, Albiger N, Lacobone M, Finco I, Patalano A, Rainey WE, Mantero F. The role of LH and GnRH receptors (LH-R and GnRH-R) in primary aldosteronism (PA): clinical and molecular data.  35th Annual Meeting of the International Aldosterone Conference, Washington, DC  2009;  ((Abstract)) 32-33
    Google Scholar
  • 42 Shenker Y, Gross MD, Grekin RJ. Central serotonergic stimulation of aldosterone secretion.  J Clin Invest. 1985;  76 1485-1490
    Google Scholar
  • 43 Duparc C, Louiset E, Perraudin V, Gobet F, Meatchi T, Plouin PF, Zennaro MC, Lefebvre H. Immunohistochemical caracterisation of mast cells in aldosterone-producing adenomas.  35th Annual Meeting of the International Aldosterone Conference, Washington, DC  2009;  ((Abstract)) 31-32
    Google Scholar
  • 44 Costa MH, Lampron A, Godbout A, Ste-Marie LG, Bourdeau I, Lacroix A. In vivo screening for aberrant hormone responsiveness in primary aldosteronism.  The Endocrine Society 89th Meeting, Toronto. 2007;  ((Abstract)) P1-P163
    Google Scholar
  • 45 Abdallah MA, Lei ZM, Li X, Greenwold N, Nakajima ST, Jauniaux E, Rao Ch V. Human fetal nongonadal tissues contain human chorionic gonadotropin/luteinizing hormone receptors.  J Clin Endocrinol Metab. 2004;  89 952-956
    Google Scholar
  • 46 Pabon JE, Li X, Lei ZM, Sanfilippo JS, Yussman MA, Rao CV. Novel presence of luteinizing hormone/chorionic gonadotropin receptors in human adrenal glands.  J Clin Endocrinol Metab. 1996;  81 2397-2400
    Google Scholar
  • 47 Godbout A, Ste-Marie LG, Larochelle P, Lamarre-Cliche M, Bourdeau I, Lacroix A. Aberrant regulation of aldosterone and cortisol secretion in patients with clinical primary aldosteronisme and bilateral macronodular adrenal hyperplasia.  The Endocrine Society 90th Meeting, San Fransisco. 2008;  ((Abstract)) P3-P271
    Google Scholar
  • 48 Tanabe A, Naruse M, Arai K, Naruse K, Yoshimoto T, Seki T, Imaki T, Miyazaki H, Zeng ZP, Demura R, Demura H. Gene expression and roles of angiotensin II type 1 and type 2 receptors in human adrenals.  Horm Metab Res. 1998;  30 490-495
    Google Scholar
  • 49 Jezova M, Armando I, Bregonzio C, Yu ZX, Qian S, Ferrans VJ, Imboden H, Saavedra JM. Angiotensin II AT(1) and AT(2) receptors contribute to maintain basal adrenomedullary norepinephrine synthesis and tyrosine hydroxylase transcription.  Endocrinology. 2003;  144 2092-2101
    Google Scholar
  • 50 Sachse R, Shao XJ, Rico A, Finckh U, Rolfs A, Reincke M, Hensen J. Absence of angiotensin II type 1 receptor gene mutations in human adrenal tumors.  Eur J Endocrinol. 1997;  137 262-266
    Google Scholar
  • 51 Nakamura Y, Son Y, Kohno Y, Shimono D, Kuwamura N, Koshiyama H, Sasano H, Matsuda T. Case of adrenocorticotropic hormone-independent macronodular adrenal hyperplasia with possible adrenal hypersensitivity to angiotensin II.  Endocrine. 2001;  15 57-61
    Google Scholar
  • 52 N’Diaye N, Tremblay J, Hamet P, De Herder WW, Lacroix A. Adrenocortical overexpression of gastric inhibitory polypeptide receptor underlies food-dependent Cushing's syndrome.  J Clin Endocrinol Metab. 1998;  83 2781-2785
    Google Scholar
  • 53 Matsukura S, Kakita T, Sueoka S, Yoshimi H, Hirata Y, Yokota M, Fujita T. Multiple hormone receptors in the adenylate cyclase of human adrenocortical tumors.  Cancer Res. 1980;  40 3768-3771
    Google Scholar
  • 54 Hirata Y, Uchihashi M, Sueoka S, Matsukura S, Fujita T. Presence of ectopic beta-adrenergic receptors on human adrenocortical cortisol-producing adenomas.  J Clin Endocrinol Metab. 1981;  53 953-957
    Google Scholar
  • 55 Katz MS, Kelly TM, Dax EM, Pineyro MA, Partilla JS, Gregerman RI. Ectopic beta-adrenergic receptors coupled to adenylate cyclase in human adrenocortical carcinomas.  J Clin Endocrinol Metab. 1985;  60 900-909
    Google Scholar
  • 56 Mazzuco TL, Thomas M, Martinie M, Cherradi N, Sturm N, Feige JJ, Chabre O. Cellular and molecular abnormalities of a macronodular adrenal hyperplasia causing beta-blocker-sensitive Cushing's syndrome.  Arq Bras Endocrinol Metabol. 2007;  51 1452-1462
    Google Scholar
  • 57 Dutton CM, Joba W, Spitzweg C, Heufelder AE, Bahn RS. Thyrotropin receptor expression in adrenal, kidney, and thymus.  Thyroid. 1997;  7 879-884
    Google Scholar
  • 58 Rossi GP, Ganzaroli C, Cesari M, Maresca A, Plebani M, Nussdorfer GG, Pessina AC. Endothelin receptor blockade lowers plasma aldosterone levels via different mechanisms in primary aldosteronism and high-to-normal renin hypertension.  Cardiovasc Res. 2003;  57 277-283
    Google Scholar
  • 59 Lacroix A, Hamet P, Boutin JM. Leuprolide acetate therapy in luteinizing hormone--dependent Cushing's syndrome.  N Engl J Med. 1999;  341 1577-1581
    Google Scholar
  • 60 Reznik Y, Lefebvre H, Rohmer V, Charbonnel B, Tabarin A, Rodien P, Lecomte P, Bardet S, Coffin C, Mahoudeau J. Aberrant adrenal sensitivity to multiple ligands in unilateral incidentaloma with subclinical autonomous cortisol hypersecretion: a prospective clinical study.  Clin Endocrinol (Oxf). 2004;  61 311-319
    Google Scholar
  • 61 Born-Frontsberg E, Reincke M, Beuschlein F, Quinkler M. Tumor size of Conn's adenoma and comorbidities.  Horm Metab Res. 2009;  41 785-788
    Google Scholar
  • 62 Mazzuco TL, Chaffanjon P, Martinie M, Sturm N, Chabre O. Adrenal Cushing's Syndrome Due to Bilateral Macronodular Adrenal Hyperplasia: Prediction of the Efficacy of beta-blockade Therapy and Interest of Unilateral Adrenalectomy.  Endocr J. 2009;  56 867-877
    Google Scholar

Correspondence

A. LacroixMD 

Professor of Medicine

Hôtel-Dieu du CHUM

3840 Saint-Urbain Street

Montréal, Québec

Canada, H2W 1T8

Telefon: +1 514 890 8000 (ext. 14930)

Fax: +1 514 412 7128

eMail: andre.lacroix@umontreal.ca

      >